COVID-19 vaccines: Open source licensing could keep Big Pharma from making huge profits off taxpayer-funded research

Governments must embrace policies that promote sharing and collective invention to create and distribute a vaccine quickly.

Timothy Ford, Professor and Chair of Biomedical and Nutritional Sciences, University of Massachusetts Lowell • conversation
Sept. 18, 2020 ~9 min

Tags:  health  medicine  covid-19  pandemic  vaccines  sars-cov-2  open-source  innovation-and-invention  process-of-innovation

Page 1 of 1